Searched for
GSK VACCINES
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...- Bharat Biotech, GSK to halve price of malaria vaccine by 2028Drugmakers Bharat Biotech and GSK will reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028, more than halving the ...
- GSK launches $2.5 bln buyback, lifts sales target after stellar Q4GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, bett...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Sanofi, GSK variant-specific Covid-19 shot found effective against Omicron"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron varian...
- GSK's RSV vaccine succeeds in late-stage trial for older adultsThe RSV vaccine is a key component of the British drugmaker's plans to boost its drug development success rate as it prepares to spin off i...
- GSK transfers malaria vaccine production to India's Bharat BiotechThe agreement includes transfer of manufacturing of the protein part of the vaccine, RTS,S/AS01, while GSK will continue to supply Bharat B...
- GSK, Sanofi say COVID-19 shot won't be ready until late 2021The companies said early trials showed the vaccine produced an "insufficient" immune response in older adults, demonstrating the need to re...
- GSK, Sanofi to make 200 mn doses available for COVID-19 vaccine allianceCOVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan. The Unit...
- GSK will price vaccine responsibly: Emmanuel Hanon, R&D HeadGSK said it was not expecting to profit from its collaborations on a vaccine candidate during the pandemic as the company rushes to offer 1...
- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- GSK's tuberculosis vaccine shows promising resultsThe new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...
- GSK Pharma trying to find out what ammunition is needed to grow: MDThe Indian arm of British drugmaker GlaxoSmithKline (GSK) is planning a major initiative to wrestle back ground it had conceded.
- GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
- Experimental Ebola vaccine appears safe in human trialsThe Ebola virus genetic material is delivered by a carrier virus (chimpanzee-derived adenovirus 3 or cAd 3) that causes a common cold in ch...
- Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- GSK in 50:50 JV with Biological E for developing paediatric vaccineThe vaccine would enable fewer injections for children thereby improving compliance in immunisation schedules.
- Govt lets GSK test H1N1 vaccineThe government has decided to let Anglo-American drug maker GlaxoSmithKline (GSK) to do ‘quick’ experiments of its swine flu vaccine on Ind...
- GlaxoSmithKline wins European nod for bird flu vaccinesBritish pharmaceuticals giant GlaxoSmithKline has won European recommendations for two vaccines aimed at combatting a potential bird flu pa...
Load More
